ADAR1 Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,900
| Closed | -$682K | – | 201 |
|
|
2024
Q4 | $682K | Buy |
+2,900
| New | +$682K | 0.14% | 93 |
|
|
2024
Q3 | – | Sell |
-1,850
| Closed | -$450K | – | 261 |
|
|
2024
Q2 | $450K | Sell |
1,850
-178,295
| -99% | -$43.3M | 0.08% | 97 |
|
|
2024
Q1 | $26.9M | Buy |
180,145
+170,645
| +1,796% | +$25.5M | 6.11% | 3 |
|
|
2023
Q4 | $1.82M | Buy |
+9,500
| New | +$1.82M | 0.65% | 29 |
|